Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-11

FDA Approved: TLANDO — Supplemental Application (Verity Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for TLANDO (testosterone undecanoate) submitted by Verity Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TLANDO (Testosterone undecanoate)

Snippet

SUPPL AP for TLANDO (TESTOSTERONE UNDECANOATE)